Correlation Between Traction Uranium and Integrated Biopharma

Can any of the company-specific risk be diversified away by investing in both Traction Uranium and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Traction Uranium and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Traction Uranium Corp and Integrated Biopharma, you can compare the effects of market volatilities on Traction Uranium and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Traction Uranium with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Traction Uranium and Integrated Biopharma.

Diversification Opportunities for Traction Uranium and Integrated Biopharma

0.0

Correlation Coefficient

Traction Uranium  Integrated Biopharma

Pay attention - limited upside

The 3 months correlation between Traction and Integrated is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Traction Uranium Corp and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Traction Uranium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Traction Uranium Corp are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Traction Uranium i.e., Traction Uranium and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Traction Uranium and Integrated Biopharma

If you would invest  19.00  in Traction Uranium Corp on June 14, 2025 and sell it today you would earn a total of  3.00  from holding Traction Uranium Corp or generate 15.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Traction Uranium Corp  vs.  Integrated Biopharma

Traction Uranium Corp

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Traction Uranium Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Traction Uranium may actually be approaching a critical reversion point that can send shares even higher in October 2025.

Integrated Biopharma

Risk-Adjusted Performance

Weakest

Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Traction Uranium and Integrated Biopharma

The main advantage of trading using opposite Traction Uranium and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Traction Uranium position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.

The idea behind Traction Uranium Corp and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.